Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis. Reske JJ, Wilson MR, Holladay J, Siwicki RA, et al. PLoS Genet 2021;17:e1009986.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Reske JJ, Wilson MR, Holladay J, Siwicki RA, et al. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis. PLoS Genet 2021;17:e1009986.
PMID: 34941867